Literature DB >> 24088113

Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria.

Jason W Bennett, Brandon S Pybus, Anjali Yadava, Donna Tosh, Jason C Sousa, William F McCarthy, Gregory Deye, Victor Melendez, Christian F Ockenhouse.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24088113     DOI： 10.1056/NEJMc1301936

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  131 in total

1.  Differential cytochrome P450 2D metabolism alters tafenoquine pharmacokinetics.

Authors:  Chau Vuong; Lisa H Xie; Brittney M J Potter; Jing Zhang; Ping Zhang; Dehui Duan; Christina K Nolan; Richard J Sciotti; Victor E Zottig; N P Dhammika Nanayakkara; Babu L Tekwani; Larry A Walker; Philip L Smith; Robert M Paris; Lisa T Read; Qigui Li; Brandon S Pybus; Jason C Sousa; Gregory A Reichard; Bryan Smith; Sean R Marcsisin
Journal:  Antimicrob Agents Chemother       Date:  2015-04-13       Impact factor: 5.191

Review 2.  8-Aminoquinoline Therapy for Latent Malaria.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2019-07-31       Impact factor: 26.132

3.  Effect of fluorescent dyes on in vitro-differentiated, late-stage Plasmodium falciparum gametocytes.

Authors:  Tamirat Gebru; Benjamin Mordmüller; Jana Held
Journal:  Antimicrob Agents Chemother       Date:  2014-09-29       Impact factor: 5.191

4.  Tafenoquine: A Step toward Malaria Elimination.

Authors:  Kuan-Yi Lu; Emily R Derbyshire
Journal:  Biochemistry       Date:  2020-02-24       Impact factor: 3.162

5.  Primaquine in Plasma and Methemoglobinemia in Patients with Malaria Due to Plasmodium vivax in the Brazilian Amazon Basin.

Authors:  José Luiz Vieira; Michelle E S Ferreira; Michelle V D Ferreira; Margarete M Gomes
Journal:  Am J Trop Med Hyg       Date:  2017-04-05       Impact factor: 2.345

Review 6.  Current therapies and future possibilities for drug development against liver-stage malaria.

Authors:  Rene Raphemot; Dora Posfai; Emily R Derbyshire
Journal:  J Clin Invest       Date:  2016-06-01       Impact factor: 14.808

7.  Development of HepG2-derived cells expressing cytochrome P450s for assessing metabolism-associated drug-induced liver toxicity.

Authors:  Jiekun Xuan; Si Chen; Baitang Ning; William H Tolleson; Lei Guo
Journal:  Chem Biol Interact       Date:  2015-10-22       Impact factor: 5.192

8.  High Efficacy of Primaquine Treatment for Plasmodium vivax in Western Thailand.

Authors:  Rhea J Longley; Piyarat Sripoorote; Pornpimol Chobson; Teerawat Saeseu; Chonlaphat Sukasem; Suparat Phuanukoonnon; Wang Nguitragool; Ivo Mueller; Jetsumon Sattabongkot
Journal:  Am J Trop Med Hyg       Date:  2016-09-06       Impact factor: 2.345

9.  Effects of MAO-A and CYP450 on primaquine metabolism in healthy volunteers.

Authors:  Norliza Mat Ariffin; Farida Islahudin; Endang Kumolosasi; Mohd Makmor-Bakry
Journal:  Parasitol Res       Date:  2019-01-31       Impact factor: 2.289

10.  Differential CYP 2D6 metabolism alters primaquine pharmacokinetics.

Authors:  Brittney M J Potter; Lisa H Xie; Chau Vuong; Jing Zhang; Ping Zhang; Dehui Duan; Thu-Lan T Luong; H M T Bandara Herath; N P Dhammika Nanayakkara; Babu L Tekwani; Larry A Walker; Christina K Nolan; Richard J Sciotti; Victor E Zottig; Philip L Smith; Robert M Paris; Lisa T Read; Qigui Li; Brandon S Pybus; Jason C Sousa; Gregory A Reichard; Sean R Marcsisin
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.